NEWS RELEASES
YEAR
-
CANBRIDGE APPOINTS MARK A. GOLDBERG AS ACTING CHIEF MEDICAL OFFICER RAISES ADDITONAL CAPITAL IN SERIES A PLUS ROUND
OCT 22, 2015
-
CANBRIDGE ACQUIRES LICENSE FOR APOGENIX’S APG101 ONCO-IMMUNOTHERAPY IN GLIOBLASTOMA FOR CHINA
JUL 16, 2015
-
CANbridge Life Sciences, Inc. Joins the MedTech Group
APR 08, 2015
-
CANbridge Life Sciences CEO, JAMES XUE, Presenting at Cancer Advanced Boston and Boston CEO
APR 02, 2015
-
James Xue, Founder and CEO of CANbridge, to Present at 2015 East West CEO conference
DEC 15, 2014
-
CANBRIDGE LIFE SCIENCES RAISES $10 MILLION IN SERIES A ROUND LED BY QIMING VENTURE PARTNERS
DEC 03, 2014
-
James Xue, Founder and CEO of CANbridge to Attend Cancer Advance Boston Conference
SEP 28, 2014
-
CANbridge Life Sciences and EUSA Pharma Form Agreement to Commericialize CAPHOSOL® in China
JUL 28, 2014
